MedTrace Logo

Zincoxide-propolis vs Zincoxide-eugenol Pulpectomy

NCT05230797 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2022-02-09

No results posted yet for this study

Summary

The clinical trial aims to evaluate the clinical and radiographic success of Zinc oxide- propolis versus Zinc oxide -Eugenol as obturating material in pulpectomy of non-vital primary teeth.

Conditions

  • Pulp Necroses

Interventions

DRUG

Zinc oxide Propolis

antibacterial and anti-inflammatory

DRUG

Zinc Oxide-Eugenol Cement

Antimicrobial and antiseptic

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-30
Primary Completion
2022-08-31
Completion
2022-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05230797 on ClinicalTrials.gov